X0306
4
2019-03-28
0
0001434316
FATE THERAPEUTICS INC
FATE
0001586892
Shoemaker Daniel D
C/O FATE THERAPEUTICS, INC.;
3535 GENERAL ATOMICS COURT #200
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2019-03-28
4
M
0
12500
2.90
A
148091
D
Common Stock
2019-03-28
4
S
0
12500
16.9362
D
135591
D
Stock Option (right to buy)
2.90
2019-03-28
4
M
0
12500
D
2026-01-07
Common Stock
12500
136300
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018.
Represents the weighted average sale price of the shares sold ranging from $16.71 to $17.30 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 8, 2016 such that this option is fully exercisable on January 8, 2020.
Not applicable.
/s/ Cindy R. Tahl, as Attorney-in-Fact
2019-03-29